New Study Reports : Europe IVD Market on eye to Reach $19,124 Million by 2023

IVD diagnostics involve non-invasive tests performed on biological samples such as, blood, urine, and tissues to detect the diseases. These tests are used for diagnosis, screening, and therapeutic monitoring of diseases. In addition, IVD tests is performed in laboratories, hospitals, and special tests such as, pregnancy tests and glucose monitoring that are performed at home.

Europe IVD market was valued at $19,124 million in 2016, and is projected to reach at $26,623 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023.

Request Sample Report @ https://www.alliedmarketresearch.com/request-sample/4352

Rise in incidence & prevalence of chronic disease, technological advancements in IVD technique, and rise in healthcare expenditure fuel the market growth during the analysis period. However, shortage of experienced healthcare professionals and lack of awareness among the population restrict the growth of the market.

Based on product type, the reagents segment held the highest market share of third-fifths in 2016, due to introduction of efficacious reagents in the market that are utilized in IVD technology for the detection of several disease.

Based on technique, the immunodiagnostics segment contributed the highest market share (one-third) in 2016, owing to the increase in prevalence of chronic diseases such as cancer that is analyzed by tissue or other diagnostic techniques and increase in demand for non-invasive techniques.

Based on application, the infectious diseases segment contributed the highest market share (two-sevenths) in 2016, owing to the increase in prevalence of infectious diseases such as tuberculosis, malaria, and pertussis that fuel the IVD market.

Based on end users, the standalone laboratory segment captured the highest market share (third-sevenths) in 2016, mainly due to availability of complex tests that are difficult to perform and increase in healthcare expenditure thus improving healthcare facilities.

Germany accounted for the highest shares in 2016, and is expected to dominate the market throughout the forecast period and is attributed to increase in incidence of chronic diseases such as tuberculosis, diabetes, and cancer. In addition, rise in demand for non-invasive technology, advancement in technology, and well-established healthcare systems is anticipated to provide new growth opportunities for the key players in the market. However, France is estimated to register the highest growth rate during the forecast period, owing to rise in government healthcare expenditure and growth in demand for healthcare devices from large pool of patient population, and improvement in healthcare infrastructure.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/4352

Key Findings of the Europe IVD Market:

• The reagents segment dominated the market in 2016, and is projected to grow at the 3.7% CAGR.
• The immunodiagnostics segment accounted for the highest share in 2016.
• The pathology segment was the major shareholder in the Europe IVD market in 2016.
• The standalone laboratory segment accounted for the highest share in 2016.
• UK was the major shareholder of Europe IVD market in 2016.
• Germany is expected to grow at the highest CAGR in the Europe IVD market.

The major players profiled in the Europe IVD market are Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.